[HTML][HTML] The interleukin-1 family: back to the future
C Garlanda, CA Dinarello, A Mantovani - Immunity, 2013 - cell.com
Interleukin-1 (IL-1) is a central mediator of innate immunity and inflammation. The IL-1 family
includes seven ligands with agonist activity (IL-1α and IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL …
includes seven ligands with agonist activity (IL-1α and IL-1β, IL-18, IL-33, IL-36α, IL-36β, IL …
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
Inflammation is a fundamental innate immune response to perturbed tissue homeostasis.
Chronic inflammatory processes affect all stages of tumour development as well as therapy …
Chronic inflammatory processes affect all stages of tumour development as well as therapy …
Iron and cancer: more ore to be mined
SV Torti, FM Torti - Nature Reviews Cancer, 2013 - nature.com
Iron is an essential nutrient that facilitates cell proliferation and growth. However, iron also
has the capacity to engage in redox cycling and free radical formation. Therefore, iron can …
has the capacity to engage in redox cycling and free radical formation. Therefore, iron can …
Macrophage plasticity and polarization in tissue repair and remodelling
A Mantovani, SK Biswas, MR Galdiero… - The Journal of …, 2013 - Wiley Online Library
Mononuclear phagocyte plasticity includes the expression of functions related to the
resolution of inflammation, tissue repair and remodelling, particularly when these cells are …
resolution of inflammation, tissue repair and remodelling, particularly when these cells are …
Obesity as a major risk factor for cancer
G De Pergola, F Silvestris - Journal of obesity, 2013 - Wiley Online Library
The number of cancer cases caused by being obese is estimated to be 20% with the
increased risk of malignancies being influenced by diet, weight change, and body fat …
increased risk of malignancies being influenced by diet, weight change, and body fat …
Cytokine patterns in patients with cancer: a systematic review
BE Lippitz - The lancet oncology, 2013 - thelancet.com
Active, but dysfunctional, immune responses in patients with cancer have been studied in
several tumour types, but owing to the heterogeneity of cancer theories of common reaction …
several tumour types, but owing to the heterogeneity of cancer theories of common reaction …
Role of macrophage targeting in the antitumor activity of trabectedin
There is widespread interest in macrophages as a therapeutic target in cancer. Here, we
demonstrate that trabectedin, a recently approved chemotherapeutic agent, induces rapid …
demonstrate that trabectedin, a recently approved chemotherapeutic agent, induces rapid …
Cancer-related inflammation
J Candido, T Hagemann - Journal of clinical immunology, 2013 - Springer
Solid tumors consist of neoplastic cells, non-malignant stromal cells, and migratory
hematopoietic cells. Complex interactions between the cell types in this microenvironment …
hematopoietic cells. Complex interactions between the cell types in this microenvironment …
Tumor associated macrophages and neutrophils in cancer
MR Galdiero, E Bonavita, I Barajon, C Garlanda… - Immunobiology, 2013 - Elsevier
The tumor microenvironment is a complex framework, in which myeloid cells play important
roles in sculpting cancer development from tumor initiation to metastasis. Immune cells are …
roles in sculpting cancer development from tumor initiation to metastasis. Immune cells are …
ROS play a critical role in the differentiation of alternatively activated macrophages and the occurrence of tumor-associated macrophages
Y Zhang, S Choksi, K Chen, Y Pobezinskaya, I Linnoila… - Cell research, 2013 - nature.com
Differentiation to different types of macrophages determines their distinct functions. Tumor-
associated macrophages (TAMs) promote tumorigenesis owing to their proangiogenic and …
associated macrophages (TAMs) promote tumorigenesis owing to their proangiogenic and …